Literature DB >> 2450463

Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma.

L J Picker1, L J Medeiros, L M Weiss, R A Warnke, E C Butcher.   

Abstract

In man, lymphocyte binding to high endothelial venules (HEVs) involves specific 85-95 kd cell surface glycoprotein(s) recognized by the monoclonal antibodies Hermes-1 and Hermes-3. These putative "homing receptor" molecule(s) are believed to play an important role in the normal regulation of lymphocyte circulation. To investigate the possibility that homing receptors also play a role in the biology of lymphoid malignancies, the authors studied over 300 cases of non-Hodgkin's lymphoma by immunohistologic staining with Hermes-1 and -3, antibodies that define two distinct epitopes on the gp 85-95 putative homing receptor molecules. Furthermore, they directly compared expression of the Hermes-3 antigen with clinical extent of disease in 57 patients with diffuse large cell lymphoma. They found that staining of the various subtypes of lymphoma was heterogeneous, and in general correlated with patterns of expression seen in benign lymphoid populations. Essentially all normal lymphoid populations examined, except germinal center B cells and most cortical thymocytes, bear a high level of homing receptor antigen. Similarly, nearly all peripheral T-cell lymphomas, diffuse small cell lymphomas of B lineage, and plasma cell tumors were positive for homing receptor antigen (95%, 97%, and 100%, respectively). Small noncleaved cell, follicular, and diffuse large cell lymphomas of B lineage, tumors having morphologic or immunologic features resembling germinal center cells, frequently failed to express Hermes-defined epitopes (81%, 41%, 25% Hermes-3-, respectively). Antigen expression in T-lymphoblastic lymphomas strongly correlated with immunophenotypic subtypes: only 8% of CD4+/CD8+ were Hermes-1+ versus 86% of CD4-/CD8- and 43% of CD4+/CD8-. Hermes-3 expression by cases of diffuse, large cell lymphoma which showed generalized lymph node involvement (a pattern strongly suggestive of HEV-mediated spread; 100% Hermes-3+, mean intensity 3.4) was higher than that of cases with localized or multifocal, contiguous involvement (consistent with lymphatic spread; 69% Hermes-3+, mean intensity 2.2), but these differences did not achieve statistical significance. The results indicate that homing receptor antigen expression, although perhaps necessary for wide-spread blood-borne lymphoma dissemination to lymphoid sites, is not in and of itself sufficient to predict such behavior in this subtype of lymphoid malignancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450463      PMCID: PMC1880677     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Homing receptors and the control of lymphocyte migration.

Authors:  S Jalkanen; R A Reichert; W M Gallatin; R F Bargatze; I L Weissman; E C Butcher
Journal:  Immunol Rev       Date:  1986-06       Impact factor: 12.988

2.  Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.

Authors:  D M Lewinsohn; R F Bargatze; E C Butcher
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

Review 3.  The regulation of lymphocyte traffic.

Authors:  E C Butcher
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies.

Authors:  A M Duijvestijn; M Kerkhove; R F Bargatze; E C Butcher
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

5.  Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules.

Authors:  E C Butcher; R G Scollay; I L Weissman
Journal:  Eur J Immunol       Date:  1980-07       Impact factor: 5.532

6.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

Authors:  R A Miller; D G Maloney; R Warnke; R Levy
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

7.  Lymphocyte recognition of lymph node high endothelium. VII. Cell surface proteins involved in adhesion defined by monoclonal anti-HEBFLN (A.11) antibody.

Authors:  R A Rasmussen; Y H Chin; J J Woodruff; T G Easton
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

8.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

9.  Patterns of presentation and relapse in the non-Hodgkin's lymphomata.

Authors:  Z Fuks; E Glatstein; H S Kaplan
Journal:  Br J Cancer Suppl       Date:  1975-03

10.  Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases.

Authors:  D D Weisenburger; B N Nathwani; L W Diamond; C D Winberg; H Rappaport
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

View more
  16 in total

Review 1.  Lymphocyte homing into the gut.

Authors:  S Jalkanen
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Intravascular (angiotropic) large-cell lymphoma ('malignant angioendotheliomatosis') with small vessel pulmonary vascular obstruction and hypercalcemia.

Authors:  J L Curtis; M L Warnock; D J Conrad; L K Helfend; H A Boushey
Journal:  West J Med       Date:  1991-07

Review 3.  Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic.

Authors:  E C Butcher
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

Review 4.  The clinical significance of malfunction of the CD44 locus in malignancy.

Authors:  D Tarin; J Bolodeoku; S J Hatfill; T Sugino; A C Woodman; K Yoshida
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

5.  Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: II. L-selectin expression mediated cell adhesion revealed by immobilized analogue carbohydrates in B-cell chronic lymphocytic leukaemia and monoclonal lymphocytosis of undetermined significance.

Authors:  G Csanaky; J A Vass; H Losonczy; M Schmelczer
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

6.  Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: I. Application of the HEV-binding assay to a clinical series.

Authors:  G Csanaky; V Kalász; G Kelényi; H Losonczy; Z Balikó; A Tóth
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

7.  Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.

Authors:  R Stauder; R Greil; T F Schulz; J Thaler; C Gattringer; T Radaskiewicz; M P Dierich; H Huber
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

8.  Adhesion receptor profile of thymic B-cell lymphoma.

Authors:  A Eichelmann; K Koretz; G Mechtersheimer; P Möller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

9.  Venular endothelium binding molecules CD44 and LECAM-1 in normal and malignant B-cell populations. A comparative study.

Authors:  P Möller; A Eichelmann; F Leithäuser; G Mechtersheimer; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Glycoprotein CD44 expression and its association with survival in breast cancer.

Authors:  H Joensuu; P J Klemi; S Toikkanen; S Jalkanen
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.